AltRx vs TrimRx: Are They the Same Company? (2026 Comparison)

No, AltRx and TrimRx Are Not the Same Company

The confusion is understandable. Both names follow the same telehealth formula, a weight-related word plus "Rx," both sell compounded GLP-1 medications through an online visit, and both ship from compounding pharmacies. But they are distinct businesses with different operators, different clinical networks, different pharmacy partners, and very different prices.

AltRx is the consumer brand of Trinity HealthCare Supply, LLC. The company is explicit that it is a technology and administrative platform: it does not employ healthcare providers or practice medicine. Medical services are delivered through OpenLoop Healthcare Partners, PC and its affiliated practices, and prescriptions are filled by four named state-licensed 503A compounding pharmacies: RedRock Pharmacy (Utah), Health Warehouse (Kentucky), Precision Medicine (New York), and Triad Rx (Alabama). AltRx lists compounded semaglutide at $89/mo and compounded GLP-1/GIP (tirzepatide) at $149/mo; across its lineup it offers both injectable and oral formulations, though the $149 tirzepatide product is a once-weekly injection. Typical processing and delivery is roughly 4-5 business days.

TrimRx operates independently at trimrx.com. TrimRx's homepage, checked October 25, 2026 (UTC), advertises GLP-1 from $179 and GLP-1+GIP from $279. Those starting offers are separate from its Terms prices. TrimRx's Terms, checked October 25, 2026 (UTC), list GLP-1 at $199 for the first month and $299 for a follow-up consultation package, and GLP-1+GIP at $349 for the first month and $399 for a follow-up consultation package. Mira's October 1, 2026 review identifies the GLP-1 program as semaglutide and GLP-1+GIP as tirzepatide. That medicine mapping is attributed secondary reporting; the primary GLP-1 price passage does not name semaglutide. The exact recurring billing period, calendar-month versus 4-week timing, required fees and all-in checkout charge were not verified. These public observations do not establish matched-term savings or a price at every dose. Confirm the medication, full charge, billing period and renewal terms in your own written quote. We cover the platform in our legitimacy review and cost guide.

Nothing on either company's site indicates shared ownership. Different operating entities, different clinical partners, different pharmacies, different prices: two separate companies that happen to sound alike. And to complete the name-collision picture, Trimi, the company publishing this page, is a third, unrelated business that readers also mix up with TrimRx.

AltRx vs TrimRx: Side-by-Side

AltRx observations below are dated August 2026. TrimRx price observations were checked October 25, 2026 (UTC), with primary program labels distinguished from Mira's October 1 secondary medicine mapping. These are not matched-period checkout quotes.

No current matched-term dollar saving is established by these observations. The structural difference discussed here is disclosure: AltRx names four compounding pharmacies and its clinical entity. Ask each company to identify the pharmacy that would fill your prescription, and verify the full charge and covered term before paying.

Whichever service you consider, the verification habit is the same. Our guide to checking a compounding pharmacy's 503A license walks through confirming a state pharmacy license in under five minutes.

What "AltRx Reviews" Should Actually Check

If you searched for AltRx reviews, you are really asking whether the service is safe and worth the money. Star ratings answer neither. For any compounded GLP-1 telehealth service, four checks matter more than testimonials:

• Named, verifiable pharmacies. AltRx passes this test: RedRock, Health Warehouse, Precision Medicine, and Triad Rx are all listed publicly, and each state board of pharmacy lets you confirm the license yourself.
• A real clinical entity. AltRx discloses that OpenLoop Healthcare Partners, PC provides its medical care, and states plainly that a prescription is never guaranteed, which is what a legitimate provider-led model looks like.
• Honest compounding disclosure. AltRx states its compounded medications have not been evaluated by the FDA for safety, efficacy, or quality. Any service that hides or hedges this disclosure is a red flag.
• All-in cost over 12 months. Starting prices do not establish the total cost of a course of treatment. Obtain a current full quote, including the covered period, renewal price and any required fees, before comparing.

On those structural checks, AltRx presents as a transparent operation. What we cannot verify from public pages, and what you should confirm directly before paying, are cancellation terms, refund policy, and how pricing behaves if your dose changes.

The Third Option: How Trimi Compares to Both

Compare the commitment as well as the charge. Trimi's compounded semaglutide is $175 billed monthly and compounded tirzepatide is $235 billed monthly, with no multi-month commitment. Monthly plans renew automatically unless renewal is turned off; turning renewal off does not refund a term already paid for. Trimi's annual plans are $1,188 upfront for compounded semaglutide ($99/month equivalent) and $1,500 upfront for compounded tirzepatide ($125/month equivalent), with a 12-month commitment. The annual plans do not renew automatically. The exact recurring billing period, calendar-month versus 4-week timing, required fees and all-in checkout charge were not verified. These public observations do not establish matched-term savings or a price at every dose. Confirm the medication, full charge, billing period and renewal terms in your own written quote.

Trimi was founded in May 2024, is headquartered in New York City, and runs the same regulatory model as AltRx and TrimRx: an online intake reviewed by a licensed provider, with medication prepared per individual prescription by a state-licensed 503A pharmacy. The compounded preparations are not FDA-approved as drugs, and a licensed provider, not the website, decides whether treatment is appropriate for you.

On effectiveness, all three services prescribe medications in the same two drug classes, and the published efficacy data comes from trials of the FDA-approved products rather than from any compounded preparation. Clinical trials show a 20.9% average body-weight reduction with tirzepatide at the 15 mg dose over 72 weeks, according to the 2022 SURMOUNT-1 study in the New England Journal of Medicine, and a 14.9% average with semaglutide over 68 weeks in the 2021 STEP 1 trial. Compounded preparations have not been studied in trials of their own, and individual results vary.

For a wider field than these three, our TrimRx alternatives comparison covers five providers on all-in price and plan terms, and our compounded tirzepatide cost guide breaks down what an all-inclusive monthly price should include. Already a TrimRx member? The switching guide covers a provider-led transition without promising continuity at the same dose or a gap-free switch.

Frequently Asked Questions